Oncotarget Using the Power of Information to Fight Diseases

ncotarget is an online journal review publisher of scientific reviews in the field of oncology, immunology, pathology, geotarget, neuroscience, endocrinology, and physiology. Over the years, Oncortarget has become more popular due to the detailed, insightful, applicable and regular reviews that impact the field of www.scijournal.org/impact-factor-of-ONCOTARGET.shtml. It has purposed to increase the impact of research through peer reviews.

To cater for the growing demand, Oncotarget releases two free issues a week online on Tuesdays and Fridays. To further increase the reach and influence of the scientific information, the accepted papers are included in the PubMed. Oncortarget is the leading publisher of research in oncology and has the largest collection of documents and more information click here.

The objective of Oncotarget is to increase the influence of scientific research by making information readily available, using the available research through insightful reviews, sharing discoveries promptly, eliminating access barriers, connecting biomedical science fields and encouraging the application of science in the fight against diseases and Oncotarget on Facebook.

The journal’s top editors are Mikhail Blagosklonny and Andrei V.Gudkov. Even after submitting an article, or review the author retains copyright ownership of the articles and allows people to download, reprint and modify the materials provided they cite the source and original author. Oncortaget uses the Creative Commons Attribution 3.0 License regulations while publishing and Oncotarget’s lacrosse camp.

Papers featured by the journal tackle disease prevalence analyzing causes, treatments and way forwards. Oncortarget papers and reviews are available on Research gate. One of the recently published study’s researches the link between Alzheimer’s Disease and Diabetes. The findings indicate that the protein found in the brain cells of Alzheimer’s Disease Patients are similar to those found in Diabetes type 2 patients. Therefore, the risk of a type 2 diabetes patients who have Alzheimer’s in future is higher. Tangles in the brain expose the patients to cognitive impairment that increases the chances of Dementia or Alzheimer’s. Most of the other articles center around developments in the cancer field. They review genomics, correlations between the different types of cancer, treatments, and therapies, and available data from previous years and learn more about Oncotarget.

Publishing of Oncotarget began in 2010. So far articles and reviews from Oncotarget have been cited over 10,000 times by other authors, scientists, and journals.

More Visit: https://twitter.com/oncotargetjrnl?lang=en